Related Experiment Videos
The introductory placebo washout: a retrospective evaluation
F W Reimherr1, M F Ward, W F Byerley
1Department of Psychiatry, University of Utah Medical Center, Salt Lake City 84132.
Psychiatry Research
|November 1, 1989
Summary
The introductory placebo washout technique in antidepressant trials may introduce confounding effects. Eliminating "hidden placebo responders" did not reduce placebo response rates and decreased treatment group differences.
Area of Science:
- Psychiatry and Clinical Psychology
- Clinical Trial Methodology
- Pharmacological Research
Background:
- The "introductory placebo washout" is a technique used in clinical trials to exclude patients who respond to placebo before initiating active treatment.
- Its effectiveness in creating a homogenous patient sample for antidepressant trials is debated, particularly concerning the identification of all placebo responders.
Purpose of the Study:
- To reanalyze a recent antidepressant trial to assess the impact of the introductory placebo washout technique.
- To determine if excluding apparent placebo responders influences the final placebo response rate and treatment group comparisons.
Main Methods:
- Reanalysis of data from a single-blind trial of an experimental antidepressant.
- Initial phase involved all patients receiving placebo, with responders on the Hamilton Rating Scale for Depression (HRSD) excluded.
- An alternative depression measure was used to identify "hidden placebo responders" missed by the HRSD.
Main Results:
- Despite the washout, a significant number of "hidden placebo responders" were identified using an alternative measure.
- Excluding these hidden responders did not lower the overall placebo response rate.
- The differences between the active treatment and placebo groups were diminished after eliminating hidden placebo responders.
Conclusions:
- The introductory placebo washout technique may have unpredictable and confounding effects on patient samples in antidepressant trials.
- This method may not effectively remove placebo responders and can potentially obscure true treatment effects.
- Further research is needed to refine patient selection methods in psychopharmacological trials.